We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 586

Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


Recycle, Recycle, Recycle: Key Considerations for Research, Medical Education, and Other Secondary Uses of Data
  • McDermott Will & Emery
  • USA
  • June 6 2018

The digitization of health care and the proliferation of electronic medical records is happening rapidly, generating large quantities of data with


Efforts to Cut Drug Prices in Medicaid
  • Manatt Phelps & Phillips LLP
  • USA
  • February 27 2018

Over the past five years, the budgets of state Medicaid programs have been challenged by the introduction of new high-cost drugs into the marketplace


Health Hacking: Dealing with the cyber threat in digital health
  • Corrs Chambers Westgarth
  • Australia
  • September 1 2017

Software and the electronic devices it controls, has become increasingly important in the healthcare industry over recent years. Digital health


The Past, Present, and Future of Government Regulation of Off-Label Communications - Part 4
  • Mintz
  • USA
  • August 14 2017

Picking up from my last installment of this series exploring the regulatory history of off-label communication, this post highlights some recent


Washington Healthcare Update - June 12, 2017
  • McGuireWoods LLP
  • USA
  • June 12 2017

On June 7, the House Energy and Commerce Committee reported out a bill reauthorizing FDA user fee programs for drugs and medical devices in a


White House Fiscal Year 2018 "Skinny Budget" Targets Discretionary Healthcare Spending
  • Sidley Austin LLP
  • USA
  • March 29 2017

On March 16, U.S. President Donald Trump released his fiscal year (FY) 2018 budget blueprint, known colloquially as the "Skinny Budget." The release


Continued Coverage of the SXSW Interactive Conference, Health Track - Accuracy: Consumer Wearables and Academic Research
  • Husch Blackwell LLP
  • USA
  • March 13 2017

Given the transformations taking place at every level in healthcare, it is no surprise that the 2017 SXSW Interactive Conference has a big spotlight


FDA Hits “Pause” on Regulation of LDTs
  • Foley & Lardner LLP
  • USA
  • February 12 2017

On January 13, 2017, the U.S. Food and Drug Administration (FDA) issued a Discussion Paper on Laboratory Developed Tests (LDTs) (LDTs) (Discussion


Rand Corporation Issues Report on U.S. Blood System
  • Foley & Lardner LLP
  • USA
  • February 6 2017

“A robust, sustainable blood system is a crucial component of every health care system.” That is how Rand Corporation’s recently issued comprehensive